Dr.Chanyue Wang: Company Chairman/Managing Director. She is responsible for the overall
management of technological projects and marketing and finance of the company. Dr. Wang is a
top-notch academic leader and entrepreneur with extensive experience in business management.
In 1995, she graduated from the University of Ghent, Belgium with a PhD. She then moved to
the United States Environmental Science and Engineering Department at Rice University for
her postdoctoral Research. In October 1998,she became a key personnel in large-scale research
projects supported by the U.S. Department of Defense. From then, she went on to pursue
pharmaceutical research at both Wyeth Pharmaceuticals Global Analysis and Development
Center and the internationally renowned TEVA Pharmaceuticals. Her research mainly consisted
of drug discovery and reporting. Since 2010,she has returned to her home country to
establish an influential role as the Senior R&D Director of Hainan Phermaceutical Co., Ltd.
as well as the co-founder and chairman of Zhejiang Meihua DingChang Pharmaceutical Co., Ltd.
ChuanYi Wang: Finance Director. Mrs. Wang graduated from Shanghai University of Finance
with a Bachelors in Economics. She has 30 years of professional experience in accounting
and financial management.Dedicated and loyal to the company, she is an essential part of
MHDC’s management team.With her experience, she is able to establish and improve the
business goals of the company all while integrating appropriate policies in handling the
company’s finances. Budgeting,decision-making, controlling fees and costs, etc. are all
handled under her supervision.
Dong Shuran (Market Fund-Raiser)
Master of International Management, University of London, UK.
Former British Kaisheng Investment Advisory Shanghai Office and Shanghai Yongda Investment Group Investment
Analyst. Have expertise in the financial industry and international management.